ACP
SRRA

Acuta Capital Partners’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Acuta Capital Partners’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-68,500
Closed -$1.49M – 45
2021
Q4 		$1.49M Buy
+68,500
New +$1.49M 0.63% 30